GlassScriptPhysician profile
Ruth K Gallatin
NPI 1598758054
$371.47
in general payments reported to CMS, 2019-2025
11 companies · $36.26 in 2025
The $36.26 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.22 · 2021: $21.54 · 2022: $41.23 · 2023: $157 · 2024: $86.18 · 2025: $36.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $91.99 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $61.64 | 2023 | Arexvy, Shingrix |
| Pfizer INC. | $49.60 | 2022-2023 | |
| Sanofi Pasteur INC. | $37.58 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $33.62 | 2022-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Avion Pharmaceuticals | $20.15 | 2023 | NP Thyroid 60 |
| Boston Scientific Corporation | $17.93 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.88 | 2024 | Xifaxan |
| Seqirus USA INC | $16.61 | 2025 | Fluad, Flucelvax |
| Lilly USA, LLC | $13.18 | 2023 | Mounjaro |
| Scilex Pharmaceuticals INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Gallatin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.